Insights

The Life Sciences CRM Landscape Is on the Verge of Change

The Life Sciences CRM Landscape Is on the Verge of Change

The Life Sciences CRM market is undergoing a significant shift. With Salesforce’s Life Sciences Cloud entering the space and legacy CRMs steadily losing momentum, forward-looking pharma organizations are already evaluating migration complexity. Their goal: to capitalize on this rare opportunity to modernize operations and strengthen HCP engagement.

The CRM transformation in life sciences — while extremely high-stakes — is neither a setback, nor a disruption. We view it as a strategic inflection point. The organizations who prepare now will emerge with stronger, AI-native systems and, subsequently, superior commercial performance.

Roman Bevz
Principal Domain Consultant, Life Sciences
The Life Sciences CRM Space Is on the Verge of Change 
* Required fields

Specifically Developed for

Pharma Commercialization Leaders

Understand how to plan a transition from legacy platforms without disrupting your sales force.

Pharma Commercialization Leaders

IT and Customer Relationship Managment Directors

Get the technical clarity to scope, plan, and execute a migration with confidence.

IT and Customer Relationship Managment Directors

Medical Affairs and Field Force Leaders

Leverage LSC4CE to enhance HCP engagement and evidence-based communication.

Medical Affairs and Field Force Leaders

Omnichannel Enablement Executives

Use a next-gen Pharma CRM to drive seamless channel orchestration, deliver personalized customer experiences, and maximize engagement impact.

Omnichannel Enablement Executives

Key Insights in the Guide

The New CRM Era in Pharma

How Salesforce’s direct entry into the life sciences market will reshape the CRM landscape.

LSC4CE’s Strategic Impact

Why this platform could redefine the CRM standard for life sciences.

The Legacy CRM Sunset

How innovation freezes and end-of-support timelines will drive urgent decisions.

Migration Readiness

Our three-tiered assessment model, powered by a proprietary technical accelerator.

FAQ

Legacy Salesforce-based CRMs will lose support by 2030. Migration planning now ensures a smooth transition, avoiding costly disruption later.
Treating it as a tech-only project. Successful transitions are business-led, data-aware, and strategically aligned.
Absolutely. Our technical accelerator and tiered service approach allow organizations of all sizes to plan out an efficient and cost-effective migration strategy.
We combine deep pharma CRM expertise with the only technical accelerator on the market designed to map, quantify, and visualize your migration scope quickly. As a certified Salesforce partner and LSC4CE Migration Alliance member, we work closely with Salesforce, ensuring full alignment with the platform’s capabilities and roadmap.